Misuse of Drugs Act 2001 (TAS)

Legislation au Tasmanian Legislation - Acts (TASLegAct) T A S M A N I A N L E G I S L A T I O N

Legislation content

Misuse of Drugs Act 2001

An Act to prohibit the misuse of drugs and activities associated with the misuse of drugs and for related purposes

[Royal Assent 17 December 2001]

Be it enacted by His Excellency the Governor of Tasmania, by and with the advice and consent of the Legislative Council and House of Assembly, in Parliament assembled, as follows:

PART 1Preliminary1Short titleThis Act may be cited as the Misuse of Drugs Act 2001. 2CommencementThis Act commences on a day to be proclaimed. 3Interpretation (1)  In this Act, unless the contrary intention appears – child means a person who has not attained the age of 18 years; conceal, in relation to something, includes conceal or disguise – (a) its source or nature; or (b) its location or movement; or (c) the rights of any person in relation to it; or (d) the identity of its owner; controlled drug means a substance, other than a growing plant, specified or described in Part 2 of Schedule 1; controlled plant means a plant specified in Part 3 of Schedule 1 or any part of such a plant; controlled precursor means a substance specified or described in Part 4 of Schedule 1; controlled substance means a controlled drug, controlled plant or controlled precursor; conveyance includes an aircraft, vehicle or vessel; cultivate includes – (a) plant a seed, seedling or cutting; and (b) graft, divide or transplant a plant; and (c) nurture, tend or grow a plant; and (d) guard or conceal a plant against discovery or interference, whether by humans or natural predators; and (e) harvest a plant, whether by picking part of the plant, by separating resin or another substance from the plant or by other means; manufacture means any process by which a substance is produced, other than the cultivation of a plant, and includes – (a) the process of extracting or refining a substance; and (b) the process of transforming the substance into a different substance; [Section 3 Subsection (1) amended by No. 3 of 2010, Sched. 1, Applied:01 Jul 2010] place includes premises; [Section 3 Subsection (1) amended by No. 7 of 2012, s. 23, Applied:01 Jul 2012] Poisons List has the same meaning as in the Poisons Act 1971; [Section 3 Subsection (1) amended by No. 76 of 2003, Sched. 1, Applied:01 Jan 2004] premises includes a conveyance; prepare, in relation to supplying a drug, includes – (a) packaging the drug; and (b) separating the drug into discrete units; product, of a plant, includes – (a) a seed of the plant; and (b) a part of the plant, whether live or dead; and (c) a substance prepared from the plant; regulations means regulations made and in force under this Act; search warrant means a warrant issued under the Search Warrants Act 1997; sell means sell, whether by wholesale or retail, and includes – (a) agree to sell; and (b) offer, or expose, for sale; and (c) keep, or possess, for sale; and (d) deal in, barter or exchange; and (e) send, forward, deliver or receive for sale; and (f) authorise, direct, cause, permit or suffer any of those things to be done; supply, in relation to a substance, includes – (a) administer the substance, whether orally, subcutaneously or by other means; and (b) offer or agree to supply the substance; traffic, in relation to a controlled substance, includes – (a) sell the substance; and (b) prepare the substance for supply with the intention of selling it or in the belief that another person intends to sell it; and (c) transport the substance with the intention of selling it or in the belief that another person intends to sell it; and (d) guard or conceal the substance with the intention of selling it or in the belief that another person intends to sell it; and (e) [Section 3 Subsection (1) amended by No. 77 of 2005, s. 4, Applied:15 Dec 2005] possess the substance with the intention of selling it; and (f) [Section 3 Subsection (1) amended by No. 77 of 2005, s. 4, Applied:15 Dec 2005] import the substance into Tasmania with the intention of selling it or in the belief that another person intends to sell it; [Section 3 Subsection (1) amended by No. 77 of 2005, s. 4, Applied:15 Dec 2005] transport includes deliver. (2)  For the purposes of this Act, a person is taken to engage in an activity if the person – (a) participates in the activity; or (b) controls or directs the activity; or (c) provides finance or another resource that allows the activity to be carried on. (3)  Without restricting the generality of the expression "possession", a controlled substance is taken to be in a person’s possession for the purposes of this Act so long as it is on any land or premises occupied by the person, or is enjoyed by the person in any place or is in the person’s order and disposition, unless the person proves that he or she had no knowledge of the substance. 3AMeaning of "trafficable quantity" and determining "aggregated trafficable quantity" [Section 3A Inserted by No. 77 of 2005, s. 5, Applied:15 Dec 2005] (1)  In this Act – trafficable quantity, of a controlled substance, means – (a) in the case of a controlled drug that is not mixed with or contained in any other substance, a quantity of the controlled drug that is not less than the quantity specified in column 3 of the table in Part 2 of Schedule 1 in relation to the controlled drug; and (b) in the case of a controlled drug that is mixed with or contained in another substance where the combined quantity of the substances is not less than the quantity specified in column 3 of the table in Part 2 of Schedule 1 in relation to the controlled drug, any quantity; and (c) in the case of a controlled plant, a quantity of the controlled plant that is not less than the quantity specified in column 3 of the table in Part 3 of Schedule 1 in relation to the controlled plant; and (d) in the case of a controlled precursor, a quantity of the controlled precursor that is not less than the quantity specified in column 3 of the table in Part 4 of Schedule 1 in relation to the controlled precursor; and (e) in the case of 2 or more controlled substances together, an aggregated trafficable quantity of the controlled substances. (2)  To determine, for the purpose of this Act, whether a quantity of 2 or more controlled substances together constitutes an aggregated trafficable quantity – (a) the quantity of each of the controlled substances is to be calculated as a fraction of the trafficable quantity of that controlled substance; and (b) the fractions calculated under paragraph (a) are to be added together; and (c) the quantity is to be taken to constitute an aggregated trafficable quantity if the total of those fractions so added together is equal to or greater than the number "1". 4Relationship with other Acts [Section 4 Amended by No. 42 of 2015, s. 40, Applied:02 Mar 2016] Nothing in this Act affects any provision made by or under the Poisons Act 1971 or the Industrial Hemp Act 2015 or renders unlawful anything done in accordance with any such provision. PART 2Major offencesDivision 1Proceedings on offences5Offences in this Part are indictable offencesThe offences in this Part are indictable offences. Division 2Manufacturing and cultivation6Manufacturing controlled drug for sale (1) A person must not manufacture a controlled drug – (a) with the intention of selling the controlled drug; or (b) in the belief that another person intends to sell the controlled drug. Penalty:  Imprisonment for a term not exceeding 21 years. (2)  [Section 6 Subsection (2) amended by No. 9 of 2004, s. 4, Applied:27 May 2004] If it is proved in proceedings for an offence under subsection (1) that the accused manufactured a trafficable quantity of a controlled drug, it is presumed, unless the accused on the balance of probabilities proves otherwise, that the accused had the relevant intention or belief concerning the sale of the manufactured drug required to constitute the offence. (3)  [Section 6 Subsection (3) omitted by No. 9 of 2004, s. 4, Applied:27 May 2004] .  .  .  .  .  .  .  .   7Cultivating controlled plant for sale (1) A person must not cultivate a controlled plant – (a) with the intention of selling the controlled plant or any of its products; or (b) in the belief that another person intends to sell the controlled plant or any of its products. Penalty:  Imprisonment for a term not exceeding 21 years. (2)  [Section 7 Subsection (2) amended by No. 9 of 2004, s. 5, Applied:27 May 2004] If it is proved in proceedings for an offence under subsection (1) that the accused cultivated a trafficable quantity of a controlled plant, it is presumed, unless the accused on the balance of probabilities proves otherwise, that the accused had the relevant intention or belief concerning the sale of the controlled plant or its products required to constitute the offence. (3)  [Section 7 Subsection (3) omitted by No. 9 of 2004, s. 5, Applied:27 May 2004] .  .  .  .  .  .  .  .   8Possessing thing intended for use in manufacture of controlled substance for saleA person must not possess any equipment, instruction or other thing – (a) with the intention of using it to manufacture and sell a controlled substance; or (b) with the intention of using it to manufacture a controlled substance in the belief that another person intends to sell the controlled substance. Penalty:  Imprisonment for a term not exceeding 21 years. 9Possessing thing intended for use in cultivation of controlled plant for saleA person must not possess any equipment, instruction or other thing with the intention of using it to – (a) cultivate and sell a controlled plant; or (b) cultivate a controlled plant in the belief that another person intends to sell the controlled plant. Penalty:  Imprisonment for a term not exceeding 21 years. 10Manufacturing controlled precursor intended for use in manufacture of controlled drugs for sale (1) A person must not manufacture a controlled precursor – (a) with the intention of manufacturing and selling a controlled drug; or (b) with the intention of manufacturing a controlled drug in the belief that another person intends to sell the controlled drug. Penalty:  Imprisonment for a term not exceeding 21 years. (2) A person must not manufacture a controlled precursor – (a) with the intention of selling the controlled precursor; and (b) in the belief that the person to whom the controlled precursor is sold intends to use it to manufacture a controlled drug. Penalty:  Imprisonment for a term not exceeding 21 years. 11Selling controlled precursor for use in manufacturing controlled drugA person must not sell a controlled precursor in the belief that the person to whom the controlled precursor is sold, or another person, intends to use it to manufacture a controlled drug.Penalty: Imprisonment for a term not exceeding 21 years. Division 3Trafficking and supply12Trafficking in controlled substance (1) A person must not traffic in a controlled substance.Penalty: Imprisonment for a term not exceeding 21 years. (2)  [Section 12 Subsection (2) amended by No. 9 of 2004, s. 6, Applied:27 May 2004] If it is proved in proceedings for an offence under subsection (1) that the accused – (a) prepared a trafficable quantity of a controlled substance for supply; or (b) transported a trafficable quantity of a controlled substance; or (c) guarded or concealed a trafficable quantity of a controlled substance; or (d) [Section 12 Subsection (2) amended by No. 77 of 2005, s. 6, Applied:15 Dec 2005] possessed a trafficable quantity of a controlled substance; or (e) [Section 12 Subsection (2) amended by No. 77 of 2005, s. 6, Applied:15 Dec 2005] imported a trafficable quantity of a controlled substance into Tasmania – it is presumed, unless the accused on the balance of probabilities proves otherwise, that the accused had the relevant intention or belief concerning the sale of the controlled substance required to constitute the offence. (3)  [Section 12 Subsection (3) omitted by No. 9 of 2004, s. 6, Applied:27 May 2004] .  .  .  .  .  .  .  .   13Procuring child to traffic in controlled substance (1) A person must not procure a child to traffic in a controlled substance.Penalty: Imprisonment for a term not exceeding 21 years. (2) For the purposes of this section, a person is taken to have procured a child to traffic in a controlled substance if the person – (a) procures the child to sell the controlled substance; or (b) with the intention of selling the controlled substance or in the belief that another person intends to sell it, procures the child to prepare the controlled substance for supply or to transport the controlled substance. 14Supplying controlled drug to childA person must not supply a controlled drug to a child.Penalty: Imprisonment for a term not exceeding 21 years. Division 4Property derived from major offences15Interpretation of Division (1)  In this Division – drug offence means an offence under Division 2 or 3 of this Part; proceeds, in relation to a drug offence, includes – (a) the proceeds of any sale involved in committing the offence; and (b) any remuneration or other reward for committing the offence; property means real or personal property, including things in action and other intangible property; property derived from a drug offence does not include a controlled drug, controlled plant or controlled precursor. (2)  For the purposes of this Division – (a) property is taken to be directly derived from a drug offence if it is – (i) all or part of the proceeds of the offence; or (ii) wholly or partly acquired by disposing of, or using, the proceeds of the offence; and (b) property is taken to be indirectly derived from a drug offence if it is wholly or partly acquired by disposing of, or using – (i) property directly derived from the offence; or (ii) property indirectly derived from the offence, including any property indirectly derived by virtue of the previous operation of subparagraph (i); and (c) property that has been directly or indirectly derived from a drug offence does not lose that status merely by being deposited with an authorised deposit-taking institution or elsewhere for credit to an account or for investment. 16Concealing, &c., property derived from drug offenceA person who knows that any property is directly or indirectly derived from a drug offence must not – (a) conceal the property; or (b) transfer the property; or (c) convert the property; or (d) remove the property from Tasmania –with the intention of evading or helping another person evade – (e) prosecution for a drug offence; or (f) the imposition or enforcement of a pecuniary penalty for a drug offence; or (g) the making or enforcement of an order for the confiscation or forfeiture of the property or any part of it. Penalty:  Imprisonment for a term not exceeding 21 years. 17Receiving property directly derived from drug offence (1)  A person must not receive any property if the person – (a) has no legal entitlement to the property; and (b) knows that the property is directly derived from a drug offence committed by another person. Penalty:  Imprisonment for a term not exceeding 21 years. (2) For the purposes of this section, property to which a person is legally entitled extends to property that is received by way of testamentary disposition, as reasonable payment for the supply of goods or services or in repayment of a lawful debt but does not extend to property received wholly or partly by way of gift. PART 3Minor offencesDivision 1Proceedings on offences18Offences in this Part are summary offencesThe offences in this Part are summary offences. 19Time for instituting proceedings (1)  A prosecution for an offence under this Part may be instituted at any time within 2 years after the commission of the offence. (2)  Subsection (1) has effect notwithstanding section 26 of the Justices Act 1959 or any other law. Division 2Manufacturing and cultivation20Manufacturing controlled precursorA person must not manufacture a controlled precursor.Penalty: Fine not exceeding 50 penalty units or imprisonment for a term not exceeding 2 years. 21Manufacturing controlled drugA person must not manufacture a controlled drug.Penalty: Fine not exceeding 50 penalty units or imprisonment for a term not exceeding 2 years. 22Cultivating controlled plantA person must not cultivate a controlled plant.Penalty: Fine not exceeding 50 penalty units or imprisonment for a term not exceeding 2 years. 22ACultivating controlled plant for sale [Section 22A Inserted by No. 27 of 2020, s. 21, Applied:01 Jul 2021] (1) A person must not cultivate a controlled plant – (a) with the intention of selling the controlled plant or any of its products; or (b) in the belief that another person intends to sell the controlled plant or any of its products. Penalty:  Fine not exceeding 100 penalty units or imprisonment for a term not exceeding 4 years. (2)  If it is proved in proceedings for an offence under subsection (1) that the accused cultivated a trafficable quantity of a controlled plant, it is presumed, unless the accused on the balance of probabilities proves otherwise, that the accused had the relevant intention or belief concerning the sale of the controlled plant or its products required to constitute the offence. Division 3Possession, use and administration23Possessing thing used for administration of controlled drugA person must not possess a utensil, appliance or other thing that is – (a) used or designed to be used in connection with the preparation, smoking, inhalation, administration or taking of a controlled drug or controlled plant; or (b) apparently intended, after some adjustment, addition or other modification, to be used in connection with the preparation, smoking, inhalation, administration or taking of a controlled drug or controlled plant. Penalty:  Fine not exceeding 50 penalty units. 24Possessing, using or administering controlled drugA person must not – (a) possess a controlled drug; or (b) use a controlled drug; or (c) administer a controlled drug to another person. Penalty:  Fine not exceeding 50 penalty units or imprisonment for a term not exceeding 2 years. 25Possessing or using controlled plant or its productsA person must not possess or use – (a) a controlled plant; or (b) a controlled plant product. Penalty:  Fine not exceeding 50 penalty units or imprisonment for a term not exceeding 2 years. Division 4Sale, supply and trafficking26Selling or supplying controlled drugA person must not sell or supply a controlled drug to another person.Penalty: Fine not exceeding 100 penalty units or imprisonment for a term not exceeding 4 years. 27Selling or supplying controlled plant or its productsA person must not sell or supply to another person – (a) a controlled plant; or (b) a controlled plant product. Penalty:  Fine not exceeding 100 penalty units or imprisonment for a term not exceeding 4 years. 27AATrafficking controlled substances [Section 27AA Inserted by No. 27 of 2020, s. 23, Applied:01 Jul 2021] (1) A person must not traffic in a controlled substance.Penalty: Fine not exceeding 100 penalty units or imprisonment for a term not exceeding 4 years. (2)  If it is proved in proceedings for an offence under subsection (1) that the accused – (a) prepared a trafficable quantity of a controlled substance for supply; or (b) transported a trafficable quantity of a controlled substance; or (c) guarded or concealed a trafficable quantity of a controlled substance; or (d) possessed a trafficable quantity of a controlled substance; or (e) imported a trafficable quantity of a controlled substance into Tasmania – it is presumed, unless the accused on the balance of probabilities proves otherwise, that the accused had the relevant intention or belief concerning the sale of the controlled substance required to constitute the offence. Division 5Miscellaneous27AUnlawful importation of controlled substance [Section 27A Inserted by No. 77 of 2005, s. 7, Applied:15 Dec 2005] A person must not import a controlled substance into Tasmania unless the person is authorised to do so by or under another law of the State.Penalty: Fine not exceeding 50 penalty units or imprisonment for a term not exceeding 2 years. 28Unlawful conduct in relation to prescriptions (1)  In this section – blank prescription form means – (a) a form that the Commission established under section 4 of the Health Insurance Commission Act 1973 of the Commonwealth has supplied or caused to be supplied to a health professional for the purposes of writing a prescription in accordance with the National Health (Pharmaceutical Benefits) Regulations 1960 of the Commonwealth; or (b) a form that a health professional has privately prepared or caused to be prepared for the purpose of writing a prescription, being a form that identifies, and purports to be a prescription form of, that health professional; conduct includes the making of an oral or written representation; [Section 28 Subsection (1) amended by No. 3 of 2010, Sched. 1, Applied:01 Jul 2010] [Section 28 Subsection (1) amended by No. 3 of 2010, Sched. 1, Applied:01 Jul 2010] health professional means – (a) a medical practitioner; and (b) a person registered under the Health Practitioner Regulation National Law (Tasmania) in the dental profession as a dentist; and (c) a person registered under the Health Practitioner Regulation National Law (Tasmania) in the nursing profession who is endorsed by the Nursing and Midwifery Board of Australia to practise as a nurse practitioner; and (d) a person who may lawfully practise as a veterinary surgeon, whether in this State or in a Territory or another State. prescription means a prescription of a health professional, for the supply of a substance comprising or consisting of a controlled drug or controlled precursor; unlawfully altered, in relation to a prescription, means altered by a person other than the health professional who issued it. (2)  A person must not – (a) forge a prescription; or (b) possess a prescription knowing it to have been forged or unlawfully altered; or (c) utter a prescription knowing it to have been forged or unlawfully altered. Penalty:  Fine not exceeding 50 penalty units or imprisonment for a term not exceeding 2 years. (3)  A person must not unlawfully alter a prescription.Penalty:  Fine not exceeding 50 penalty units or imprisonment for a term not exceeding 2 years. (4)  A person must not obtain a prescription by means of conduct that the person knows to be false, misleading or deceptive.Penalty:  Fine not exceeding 50 penalty units or imprisonment for a term not exceeding 2 years. (5)  A person must not, without lawful excuse, possess a blank prescription form.Penalty:  Fine not exceeding 50 penalty units or imprisonment for a term not exceeding 2 years. PART 4EnforcementDivision 1Police powers29Power to seize controlled substances, &c. (1)  In this section, prescribed belief means a reasonable belief that a controlled substance or other thing in relation to which an offence under this Act has been committed is – (a) [Section 29 Subsection (1) amended by No. 77 of 2005, s. 8, Applied:15 Dec 2005] in the possession of a person in any place; or (b) [Section 29 Subsection (1) amended by No. 77 of 2005, s. 8, Applied:15 Dec 2005] on or in a conveyance in any place; or (c) [Section 29 Subsection (1) amended by No. 77 of 2005, s. 8, Applied:15 Dec 2005] on an animal in any place. (2)  A police officer who has a prescribed belief may, without warrant and with such assistance as the police officer reasonably considers necessary, take such one or more of the following actions as may be applicable in the circumstances: (a) search the relevant person and detain that person for the purpose of carrying out the search; (b) search the relevant conveyance or animal and detain it for the purpose of carrying out the search; (c) seize the relevant conveyance or animal; (d) seize anything that may be evidence of an offence under this Act. (2A)  [Section 29 Subsection (2A) inserted by No. 77 of 2005, s. 8, Applied:15 Dec 2005] However, subsection (2) does not apply to private premises unless the police officer forms the prescribed belief only after having lawfully entered the premises. (3)  The police officer, and any person assisting the police officer, may use such force as is necessary and reasonable in the circumstances. (4)  A police officer who searches or is empowered to search a person pursuant to subsection (2) or any other Act may arrest the person without warrant if the police officer reasonably believes that the person has committed an offence under this Act. (5)  In this section, a reference to a search of a person includes a reference to any clothing worn by the person and anything that may be in the person’s possession. 30Power to conduct personal searches (1)  In this section – body cavity means rectum or vagina; strip search means a search, other than a body cavity search ordered by a magistrate under this section, in which the person searched is required to remove most or all of his or her clothes. (2)  [Section 30 Subsection (2) amended by No. 77 of 2005, s. 9, Applied:15 Dec 2005] Where a police officer detains a person for the purpose of search under section 29 or 33, the following provisions apply: (a) if the person is female and it is proposed to conduct a strip search, a female police officer is to conduct it; (b) if the person is male and it is proposed to conduct a strip search, a male police officer is to conduct it; (c) if the search involves the application of force to the person, the police officer must give the Commissioner of Police a written report about the search within 7 days, including particulars of the circumstances that gave rise to the application of force; (d) if the police officer reasonably suspects that a controlled substance may be present in one or more of the person’s body cavities and wishes to determine whether or not that is the case, the police officer must cause the person to be brought before a magistrate; (e) the magistrate before whom the person is brought may make an order that the person’s body cavity or cavities specified in the order may be searched by a medical practitioner. (3)  The magistrate’s order, if made, is sufficient authority for a medical practitioner to search the person’s body cavity or cavities specified in the order. (4)  Notwithstanding subsection (3)  – (a) the person is first to be told that he or she may ask for the search to be conducted by a medical practitioner of the same sex as that person; and (b) if the person does so ask, the search is not to be conducted except by a medical practitioner of that sex unless it is not reasonably practicable in the circumstances for such a medical practitioner to be present. (5)  The magistrate’s order also authorises – (a) a medical practitioner who is to conduct the search to ask another person to help with the search; and (b) the other person to give that help. (6)  Unless it is not reasonably practicable in the circumstances, the person asked to help is to be of the same sex as the person to be searched. (7)  If the person subject to the magistrate’s order refuses or fails to submit to the search, the medical practitioner and the helper, if any, may use reasonable force to enable the search to be conducted. 31Power to require information (1) A police officer who seizes a controlled substance or other thing under a search warrant or section 29 may require the person from whom the controlled substance or thing was seized to state – (a) the person’s name and the address of the person’s place of residence or of the place where the person proposes next to reside; and (b) the place at which, and the person from whom, the first-mentioned person obtained the controlled substance or thing. (2)  A person must not – (a) fail to comply with a requirement made under subsection (1) in relation to the particulars referred to in paragraph (a) of that subsection; or (b) without reasonable excuse, fail to comply with a requirement made under subsection (1) in relation to the particulars referred to in paragraph (b) of that subsection when it is within the person’s power so to comply; or (c) in response to a requirement made under subsection (1), give information that the person knows to be false or misleading. Penalty:  Fine not exceeding 10 penalty units. (3) A police officer who searches or is empowered to search a person under a search warrant or section 29 may arrest the person without warrant if – (a) the person fails to comply with a requirement made under subsection (1); or (b) in response to such a requirement, the person gives information that the police officer reasonably believes to be false or misleading. 32Power to pursue suspect onto private propertyWhere – (a) a police officer reasonably believes that a person has committed an offence under this Act; and (b) the person flees from the police officer’s presence while the police officer, or another police officer, is trying to arrest the person or exercise another power under this Act in relation to the person; and (c) the police officer, or another police officer, immediately pursues the person and the pursuit continues without interruption; and (d) during the pursuit the person enters a private residence or another place that is not a public place – the pursuing police officer may, without warrant and using no more force than is reasonably necessary for the purpose, enter the private residence or other place notwithstanding that it is not a public place. 33Power when executing search warrantA police officer executing a search warrant in relation to any place may – (a) arrest without warrant any person found at the place who the police officer reasonably believes has committed an offence under this Act; and (b) search any person found at the place and detain any such person for that purpose. Division 2Matters relevant to proceedings34Prosecution witness need not disclose source of informationA witness for the prosecution in proceedings under this Act is not obliged to disclose – (a) the fact that the witness received any information; or (b) the nature of any information received by the witness; or (c) the name of the person who gave the witness any information. 35Offences by bodies corporate (1) If a body corporate commits an offence under this Act each person concerned in the management of the body corporate is taken also to have committed the offence and may be convicted of the offence unless the person proves that the act or omission constituting the offence took place without the person’s knowledge or consent or contrary to the person’s orders or directions. (2)  A person referred to in subsection (1) may be convicted of an offence under this Act whether or not the body corporate is charged with or convicted of the offence. 36Children not liable for conduct constituting certain offencesA person is not criminally liable for an offence under section 13 or 14 if, at the time of the conduct constituting the offence, the person was a child. 36AAlternative convictions [Section 36A Inserted by No. 9 of 2004, s. 7, Applied:27 May 2004] (1)  A person who is indicted for but found not guilty of an offence under section 6(1) may be convicted of an offence under section 21 if the evidence in the proceedings on the indictment establishes that the person committed that other offence. (2)  A person who is indicted for but found not guilty of an offence under section 7(1) may be convicted of either or both of the following offences if the evidence in the proceedings on the indictment establishes that the person committed that other offence or, if applicable, those other offences: (a) an offence under section 22; (b) an offence under section 25. (3)  [Section 36A Subsection (3) amended by No. 77 of 2005, s. 10, Applied:15 Dec 2005] A person who is indicted for but found not guilty of an offence under section 12(1) may be convicted of an offence under section 24, 25 or 27A if the evidence in the proceedings on the indictment establishes that the person committed that other offence. (4)  This section has effect despite anything to the contrary in Chapter XXXIX of Part IX of the Criminal Code. 36BCosts of analysis or examination [Section 36B Inserted by No. 9 of 2004, s. 7, Applied:27 May 2004] (1)  In this section, analyst has the same meaning as in the Poisons Act 1971. (2)  Where, for proceedings under this Act, the prosecutor has caused the substance or plant to which the proceedings relate to be analysed or examined by an analyst, the court may, in case of a conviction, assess the reasonable expense of and attending the analysis or examination and award it against the defendant as part of the costs of the prosecutor. (3)  In addition to the costs, if any, under subsection (2), the court may assess and award against the defendant – (a) as part of the costs of the prosecutor, the expenses incurred by the prosecutor while engaged in travelling to and attending the trial, including the proportionate part of the prosecutor’s salary while so engaged; and (b) if an analyst has given evidence in the proceedings, such costs in respect of the analyst’s attendance as the court may determine. Division 3Forfeiture and disposal37Crown becomes owner of controlled substances, &c., that are seized, surrendered or found [Section 37 Substituted by No. 77 of 2005, s. 12, Applied:15 Dec 2005] (1) This section applies if a controlled substance or prescription form is – (a) seized by a police officer under a search warrant or section 29; or (b) voluntarily surrendered to a police officer; or (c) found by a police officer. (2) The controlled substance or prescription form – (a) becomes the property of the Crown as soon as it is seized, surrendered or found; and (b) may be disposed of as the Minister directs. 37ADisposal, &c., of evidence that cannot be practicably or safely held [Section 37A Inserted by No. 77 of 2005, s. 12, Applied:15 Dec 2005] (1)  In this section – evidentiary material means a controlled substance or hazardous chemical that – (a) has been seized by or otherwise come into the possession of a police officer; and (b) is or could be relevant to proceedings or prospective proceedings for an offence against this Act; hazardous chemical means a chemical or other substance that – (a) is used or capable of being used in connection with the manufacture of a controlled substance; and (b) is, by reason of its combustibility, volatility, toxicity or some other quality, unsafe or potentially unsafe. (2)  This section applies if the Commissioner of Police is satisfied on reasonable grounds that it is impracticable or unsafe to hold or continue holding any evidentiary material. (3)  The Commissioner of Police may cause the evidentiary material to be – (a) rendered safe or inert (if necessary by treating, repackaging or breaking up the material); or (b) destroyed or otherwise disposed of. (4)  However, before any action is taken under subsection (3), the Commissioner of Police must – (a) if the evidentiary material is or could be relevant to indictable proceedings or prospective indictable proceedings against this Act, consult the Director of Public Prosecutions; and (b) ensure that – (i) 2 or more samples are taken of the evidentiary material; and (ii) each of those samples is a true representation of the nature of the evidentiary material. (5)  The Commissioner must ensure that the samples so taken are kept securely for as long as they are reasonably likely to be required for evidentiary purposes. (6)  The Minister may – (a) issue the Commissioner of Police with written guidelines regarding the administration of this section; and (b) amend or rescind any such guidelines. (7)  The Commissioner of Police must comply with the Minister’s guidelines. (8)  The Minister’s guidelines are not – (a) statutory rules for the purposes of the Rules Publication Act 1953; or (b) instruments of a legislative character for the purposes of the Subordinate Legislation Act 1992. 38Forfeiture of property on convictionA court that convicts or finds a person guilty of an offence under this Act may, in addition to any other order that it may make, order that any property of the person used in the commission of the offence is forfeited to the Crown. Division 4Authorisation of possession and supply for certain purposes38AInterpretation of Division [Section 38A of Part 4 Inserted by No. 7 of 2016, s. 4, Applied:20 May 2016] (1)  In this Division – ancillary action, in relation to an authorisation, means an action that is – (a) directly related to achieving an authorised purpose; and (b) reasonably required to be carried out in order to enable that purpose to be achieved; authorisation means an authorisation issued under section 38B(1); authorised person means a person to whom an authorisation has been issued under section 38B(1); authorisation purpose, in relation to an authorisation, means a purpose specified, in accordance with section 38B(4)(b), in the authorisation; correctional officer means a person, appointed under section 5 of the Corrections Act 1997, whose duties under that Act include the training or use of dogs in the detection of controlled substances; Director of Corrective Services means the Director of Corrective Services appointed under section 5 of the Corrections Act 1997; employee means a person employed in any Agency of which the Commissioner of Police is the Head of Agency. (2)  Without limiting the generality of the meaning of supply in section 3, supply, in relation to a controlled substance – (a) includes transport and delivery, or either, of the controlled substance; but (b) does not include sale or use, or provision for use, of the controlled substance for any purpose other than an authorisation purpose specified in the authorisation in accordance with which the supply occurs. 38BAuthorisation of possession and supply of controlled substances for certain purposes [Section 38B of Part 4 Inserted by No. 7 of 2016, s. 4, Applied:20 May 2016] (1)  The Commissioner of Police may authorise – (a) a police officer; or (b) an employee; or (c) a correctional officer – (an authorised person) to possess and supply controlled substances for the purposes, for which the authorisation may be issued, that are specified in the authorisation, and to carry out any ancillary actions. (2)  The purposes for which an authorisation may be issued are – (a) for the training, and use, by police officers or correctional officers, of dogs used, or to be used, in the detection of controlled substances; and (b) for the transport and delivery of samples of controlled substances to – (i) other police officers or correctional officers; or (ii) other persons who are police officers for the purposes of an Act of another State, a Territory or the Commonwealth. (3)  An authorisation must be in writing and signed by the Commissioner of Police. (4)  An authorisation must specify the following: (a) the name of the authorised person to whom the authorisation relates; (b) the purposes for which the authorised person has been issued the authorisation; (c) the conditions, if any, on which the authorisation has been issued; (d) the period, of not more than one year, for which the authorisation remains in effect; (e) the date on which the authorisation is signed by the Commissioner of Police. (5)  The Commissioner of Police is only to issue to a person an authorisation that is to be in effect for a period that is as long as is reasonably necessary to enable the authorisation purposes to be fulfilled. (6)  Despite any other Act or law of this jurisdiction, an authorised person who engages in conduct (whether in this jurisdiction or otherwise) that, but for this section, would constitute an offence is not criminally responsible in relation to the conduct if he or she engages in the conduct under and in accordance with an authorisation in relation to him or her that is in effect. 38CVariation or cancellation of authorisation [Section 38C of Part 4 Inserted by No. 7 of 2016, s. 4, Applied:20 May 2016] (1)  The Commissioner of Police – (a) may vary or cancel an authorisation at any time; and (b) must cancel an authorisation if he or she is satisfied that the authorisation is no longer necessary. (2)  The Commissioner of Police must give to an authorised person written notice of the variation or cancellation of the authorisation. (3)  A notice under subsection (2) must specify why the authorisation to which the notice relates is varied or cancelled. (4)  A notice under subsection (2) of the variation or cancellation of an authorisation to which the notice relates takes effect – (a) on the day on which the notice is given to the person; or (b) if the notice specifies that it takes effect on a later day – on the day so specified. 38DPowers under Division non-delegable [Section 38D of Part 4 Inserted by No. 7 of 2016, s. 4, Applied:20 May 2016] Despite this or any other Act, the Commissioner of Police may not delegate to another person, or authorise another person to exercise, a power of the Commissioner of Police under section 38B or 38C. 38EAuthorisation does not limit other powers [Section 38E of Part 4 Inserted by No. 7 of 2016, s. 4, Applied:20 May 2016] Nothing in this Division is to be taken to require a police officer to be authorised for purposes other than an authorisation purpose. 38FAuthorised person to provide report about authorisation [Section 38F of Part 4 Inserted by No. 7 of 2016, s. 4, Applied:20 May 2016] (1)  An authorised person must, as soon as practicable after – (a) the end of each financial year in which his or her authorisation was in effect; or (b) his or her authorisation ceases to be in effect – provide to the Commissioner of Police a written report in relation to the authorisation. (2)  A report, by an authorised person under subsection (1), in relation to an authorisation is to contain the following details: (a) the quantity, and a description, of each controlled substance that was possessed by the authorised person, or supplied by the authorised person to another person, under the authorisation; (b) any ancillary actions taken by the authorised person; (c) the name of any other person to whom a controlled substance was supplied by the authorised person under the authorisation and the address at which the controlled substance was so supplied; (d) if the controlled substance was supplied by the authorised person to another person for delivery to a third person, the name and address of the third person to whom the controlled substance was to be delivered; (e) each day in which the authorised person was in possession of the controlled substance. 38GCommissioner of Police to keep certain records [Section 38G of Part 4 Inserted by No. 7 of 2016, s. 4, Applied:20 May 2016] The Commissioner of Police must cause to be kept records of – (a) all authorisations; and (b) all notices under section 38C; and (c) all reports provided to him or her under section 38F(1). 38HCommissioner of Police to report to Ombudsman [Section 38H of Part 4 Inserted by No. 7 of 2016, s. 4, Applied:20 May 2016] (1)  The Commissioner of Police is to provide to the Ombudsman, as soon as practicable after the end of each financial year, a report (an operational report) containing – (a) the number of authorisations issued during the financial year; and (b) the purposes for which the authorisations were issued; and (c) a summary of the details specified in each report received by the Commissioner of Police under section 38F(1). (2)  The summary included, in the report under subsection (1), in accordance with subsection (1)(c) is not required to contain any details that may, in the opinion of the Commissioner of Police, compromise the lawful carrying out of the duties of a police officer. 38IReports by Ombudsman [Section 38I of Part 4 Inserted by No. 7 of 2016, s. 4, Applied:20 May 2016] (1)  The Ombudsman must, as soon as practicable after receiving an operational report under section 38H(1), prepare a report setting out – (a) a summary of the matters provided in the operational report; and (b) the Ombudsman’s opinion as to the comprehensiveness and adequacy of the records of the Commissioner of Police kept under section 38G; and (c) the Ombudsman’s opinion as to whether the authorisations to which the operational report relates have been effective and appropriate; and (d) the Ombudsman’s comments and suggestions as to how the issue, supervision and implementation of authorisations may be improved. (2)  The Ombudsman must include his or her report under subsection (1) in the annual report prepared in accordance with section 30 of the Ombudsman Act 1978. PART 5Miscellaneous39Regulations (1) The Governor may make regulations for the purposes of this Act. (2) The regulations may be made so as to apply differently according to matters, limitations or restrictions, whether as to time, circumstance or otherwise, specified in the regulations. (3) The Governor may make regulations of a savings or transitional nature consequent on the enactment of this Act. (4)  A provision of a regulation made pursuant to subsection (3) may, if the regulation so provides, take effect on the day proclaimed under section 2 or a later day. 40Amendment of Schedule 1 (1)  In this section, component means a clause, subclause, paragraph or subparagraph. (2)  The Governor may, by order, amend Part 1 of Schedule 1 by doing any one or more of the following: (a) inserting a new component or expression; (b) omitting a component or expression; (c) omitting a component or expression and substituting another component or expression. (3)  The Governor may, by order, amend Part 2, 3 or 4 of Schedule 1 by doing any one or more of the following: (a) inserting a new item in any table; (b) omitting an item from any table; (c) omitting an item from any table and substituting another item. (4)  The provisions of section 47(3), (3A), (4), (5), (6) and (7) of the Acts Interpretation Act 1931 apply to an order under this section as if the order were regulations within the meaning of that Act. 41Administration of ActUntil provision is made in relation to this Act by order under section 4 of the Administrative Arrangements Act 1990  – (a) the administration of this Act is assigned to the Minister for Justice and Industrial Relations; and (b) the department responsible to the Minister for Justice and Industrial Relations in relation to the administration of this Act is the Department of Justice and Industrial Relations. Schedule 1Controlled substances and trafficable quantities

Sections 3 and 40

PART 1Interpretation 1.    In this Schedule – (a) [Part 1 of Schedule 1 Amended by No. 7 of 2012, s. 24, Applied:01 Jul 2012] .  .  .  .  .  .  .  .   (b) the letter "S", followed immediately by a number, is a reference to the schedule to the Poisons List having that number; and (c) a reference to a substance ("the relevant substance") includes – (i) every salt, active principle or derivative of the relevant substance and every salt of such an active principle or derivative; and (ii) a preparation or admixture containing any proportion of the relevant substance; and (iii) every ester or ether of the relevant substance and every salt of such an ester or ether; and (iv) every substance that is, in relation to the relevant substance, a stereoisomer or structural isomer (with the same constituent groups); and (v) every substance that is, in relation to a substance referred to in paragraph (iv), a substance of a kind described in paragraph (i), (ii) or (iii); and (vi) any substance that is otherwise a homologue, analogue or chemical derivative of, or substantially similar in chemical structure to, the relevant substance. PART 2Controlled drugs

Column 1

Item

Column 2

Controlled drug

Column 3

Trafficable quantity

1. 

Acetorphine

2. 

Acetyl-alpha-methylfentanyl

3. 

N-acetylanthranilic acid

4. 

Acetyldihydrocodeine

5. 

Acetylmethadol

6. 

Acetylmorphines

7. 

Alfentanil

8. 

Alkoxyamphetamines and substituted alkoxyamphetamines except when separately specified in this Schedule

25g

9. 

Alkoxyphenylethylamines and substituted alkoxyphenylethylamines except when separately specified in this Schedule

10. 

Alkylthioamphetamines and substituted alkylthioamphetamines except when separately specified in this Schedule

25g

10A. 

Allylescaline

11. 

Allylprodine

12. 

Alphacetylmethadol

13. 

Alphameprodine

14. 

Alphamethadol

15. 

Alpha-methylfentanyl

16. 

Alpha-methylthiofentanyl

17. 

Alphaprodine

18. 

Alprazolam

19. 

2-amino-1-chloro-1-phenylpropane

20. 

2-amino-1-(2,5-dimethoxy-4-methyl)phenylpropane (otherwise known as2,5-dimethoxy-4-methylamphetamineor2,5-dimethoxy-4-α-dimethylphenethylamineorSTPorDOM)

21. 

5-(2-aminopropyl)indan and substituted 5-(2-aminopropyl)indans except when separately specified in this Schedule

22. 

Amphetamine

(a) in individual packages

20 packages

(b) in any other form

25g

23. 

Amylobarbitone

24. 

Anabolic and androgenic steroidal agents (including those separately specified in S4)

25. 

Androisoxazole

26. 

Anileridine

27. 

Benactyzine and other substances structurally derived from diphenylmethane with ataractic properties

28. 

Benzethidine

29. 

Benzodiazepine derivatives not elsewhere specified in this Schedule

29AA. 

1-(1,3-benzodioxol-5-yl)-2-(methylamino)-1-pentanone (otherwise known as pentylone)

25g or 20 units

29A. 

1-(benzo[d][1,3]dioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one otherwise known as methylenedioxypyrovalerone or MDPV

25 grams (or 20 Units)

29B. 

1-benzofuran-5-ylpropan-2-amine (otherwise known as 5-(2-aminopropyl)benzofuran or 5-APB)

25g or 20 units

29C. 

1-benzofuran-6-ylpropan-2-amine (otherwise known as 6-(2-aminopropyl)benzofuran or 6-APB)

25g or 20 units

29D. 

Benzoylindoles

5g or 20 units

30. 

Benzylmorphine

30A. 

Benzylpiperazine (otherwise known as BZP)

31. 

Betacetylmethadol

32. 

Beta-hydroxyfentanyl

33. 

Beta-hydroxy-3-methylfentanyl

34. 

Betameprodine

35. 

Betamethadol

36. 

Betaprodine

37. 

Bezitramide

38. 

Boldenone (otherwise known as dehydrotestosterone)

39. 

Bromazepam

40. 

Bromides (S4)

40A. 

1-(8-Bromobenzo[1,2-b;4,5-b’]difuran-4-yl)-2-aminopropane otherwise known as Bromo-dragonfly

25 grams (or 20 Units)

41. 

4-bromo-3,5-dimethoxyamphetamine (otherwise known as BDMA)

42. 

4-bromo-2,5-dimethoxyphenethylamine (otherwise known as BDMPEA)

25g

42A. 

2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (otherwise known as 25B-NBOMe)

25g or 20 units

43. 

3-bromo-4-methoxyamphetamine

44. 

4-bromo-3-methoxyamphetamine

25g

46. 

Bromvaletone

47. 

Bufotenine

48. 

Buprenorphine

5g

48A. 

1,4-butanediol when intended for human ingestion

49. 

Butobarbitone

50. 

Butorphanol

50A. 

4-butyrolactone (otherwise known as gamma-butyrolactone (GBL)) when intended for human ingestion

51. 

Captodiame

52. 

Carfentanyl

53. 

Cathine

54. 

Cathinone

55. 

Chloral hydrate (S4)

56. 

Chlorbutol (S4)

57. 

Chlordiazepoxide

58. 

Chlormethiazole

59. 

Chlormezanone

59A. 

4-chloro-2,5-dimethoxyamphetamine

25 grams (or 20 Units)

59B. 

2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (otherwise known as 25C-NBOMe)

25g or 20 units

61. 

1-chlorophenyl-2-methylaminopropane (otherwise known as 2-(N-methylamino)-1-chloro-1-propane)

62. 

Clobazam

63. 

Clonazepam

64. 

Clonitazene

65. 

Clorazepate

66. 

Clostebol (otherwise known as 4-chloro-testosterone)

67. 

Cocaine

(a) in individual packages

20 packages

(b) in any other form

25g

68. 

Coca leaf

69. 

Codeine

25g

70. 

Codeine-N-oxide

71. 

Codoxime

72. 

4-cyano-2-dimethylamino-4,4-diphenylbutane

73. 

4-cyano-1-methyl-4-phenylpiperidine (otherwise known as pethidine intermediate A)

74. 

Cyclobarbitone

74C. 

l-cyclohexyl-4-(1,2-diphenylethyl)piperazine (otherwise known as MT-45)

74E. 

Cyclohexylphenols

5g or 20 units

74H. 

Darbepoetin alfa

75. 

Desomorphine

76. 

Dexamphetamine

25g

77. 

Dextromoramide

10g

78. 

Dextropropoxyphene (S4)

79. 

Diacetylmorphine (otherwise known as heroin)

(a) in individual packages

20 packages

(b) in any other form

25g

79A. 

N,N-Diallyl-5-Methoxytryptamine (otherwise known as 5-MeO-DALT)

5g or 20 units

80. 

Diampromide

81. 

Diazepam

81A. 

Dibenzopyrans

5g or 20 units

81M. 

3,4-dichloro-N-(2-(dimethylamino)cyclohexyl)-N-methylbenzamide (otherwise known as U-47700)

82. 

Diethylpropion

83. 

Diethylthiambutene

84. 

N,N-diethyltryptamine (otherwise known as DET)

85. 

Difenoxin

85A. 

1-(2,3-dihydro-1-benzofuran-5-yl)propan-2-amine (otherwise known as 5-(2-aminopropyl)-2,3-dihydrobenzofuran or 5-APDB)

25g or 20 units

85B. 

1-(2,3-dihydro-1-benzofuran-6-yl)propan-2-amine (otherwise known as 6-(2-aminopropyl)-2,3-dihydrobenzofuran or 6-APDB)

25g or 20 units

86. 

Dihydrocodeine

86A. 

6-7-dihydro-5H-cyclopenta[f][1,3]benzodioxol-6-amine otherwise known as 5,6-Methylenedeioxy-2-aminoindane or MDAI

25 grams (or 20 Units)

86B. 

2,3-dihydro-1H-inden-2-amine or 2-aminoindane (otherwise known as 2-AI)

25g or 20 units

87. 

Dihydromorphine

88. 

Dimenoxadol

89. 

Dimepheptanol

90. 

2,4-dimethoxyamphetamine

91. 

3,4-dimethoxyamphetamine

92. 

2,5-dimethoxyamphetamine (otherwise known as 2,5-dimethoxy-α-methylphenyl-ethylamine or DMA)

(a) in individual packages

20 packages

(b) in any other form

25g

93. 

2,5-dimethoxy-4-bromoamphetamine (otherwise known as DOB)

25g

94. 

3,4-dimethoxy-5-ethoxyamphetamine

25g

95. 

2,5-dimethoxy-4-ethoxyamphetamine

25g

96. 

4,5-dimethoxy-2-ethoxyamphetamine

25g

97. 

2,5-dimethoxy-4-ethyl-α-amphetamine (otherwise known as 2,5-dimethoxy-4-ethyl-α-methylphenylethylamine or DOET)

25g

97AA. 

2,5-dimethoxy-4-ethylphenethylamine

25 grams (or 20 Units)

97A. 

2,5-dimethoxy-4-ethylthiophenethylamine (otherwise known as 2C-T-2)

97B. 

2,5-dimethoxy-4-iodophenethylamine (otherwise known as 2C-I)

98. 

2,3-dimethoxy-4,5-methylenedioxyamphetamine

25g

99. 

2,5-dimethoxy-3,4-methylenedioxyamphetamine

25g

99A. 

2-(2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (otherwise known as 25H-NBOMe)

100. 

3,4-dimethoxyphenylethylamine

100AA. 

2,5-dimethoxy-4-propylphenethylamine otherwise known as 2C-P

5 grams (or 20 Units)

100A. 

2,5-dimethoxy-4-(N)-propylthiophenethylamine (otherwise known as 2C-T-7)

101. 

3-(2-dimethylaminoethyl)-4-hydroxyindole (otherwise known as psilocine or psilotsin)

101A. 

N,N-Dimethylamphetamine (Dimetamfetamine)

102. 

Dimethylthiambutene

103. 

3-(1,2-dimethylheptyl)-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran (otherwise known as DMHP)

104. 

N,N-dimethyltryptamine (otherwise known as DMT)

105. 

Dioxaphetyl butyrate

106. 

Diphenoxylate (S8)

106A. 

1-(1,2-diphenylethyl)piperidine (otherwise known as diphenidine)

107. 

Dipipanone

108. 

Dronabinol (also known as delta-9-tetrahydrocannabinol or delta-9-THC) when packed and prepared for therapeutic use

109. 

Drostanolone

110. 

Drotebanol

111. 

Ecgonine

112. 

Ephedrine

30g

112M. 

Epoetin alfa

112N. 

Epoetin beta

113. 

Erythropoietin

113D. 

Erythropoietins

114. 

Ethinamate

115. 

N-ethyl-α-methyl-3,4-(methylenedioxy) phenethylamine (otherwise known as N-ethyl MDA)

116. 

Ethylamphetamine

25g

116A. 

ethylcathinone

25 grams (or 20 Units)

117. 

4,5-ethylenedioxy-3-methoxyamphetamine

25g

118. 

Ethylmethylthiambutene

119. 

Ethylmorphine

119M. 

Ethylnaphthidate (otherwise known as HDEP-28)

120. 

Ethyloestronol

120A. 

Ethylphenidate

25g

121. 

Eticyclidine (otherwise known as N-ethyl-1-phenylcyclohexylamine or PCE)

121A. 

Etodesnitazene (otherwise known as Etazene)

122. 

Etonitazene

123. 

Etorphine

124. 

Etoxeridine

125. 

Fenetylline

126. 

Fentanyl

200mg

127. 

Flunitrazepam

500mg

127A. 

2-fluoromethcathinone

25 grams (or 20 Units)

127B. 

3-fluoromethcathinone

25 grams (or 20 Units)

127C. 

4-fluoromethcathinone

25 grams (or 20 Units)

127D. 

4-fluoro-N-methylamphetamine

25 grams (or 20 Units)

127DA. 

3-fluorophenmetrazine

(a) in individual packages

20 packages

(b) in any other form

25g

127E. 

1-(p-fluorophenyl)piperazine

25 grams (or 20 Units)

128. 

Fluoxymesterone

129. 

Flurazepam

130. 

Furethidine

131. 

Glutethimide

132. 

Harmala alkaloids except in herbs, or preparations, for therapeutic use –

(a) containing 0.1% or less of harmala alkaloids; or

(b) in divided preparations containing 2mg or less of harmala alkaloids per recommended daily dose

133. 

3-hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran (otherwise known as parahexyl)

134. 

Hydrocodone

135. 

Hydromorphinol

136. 

Hydromorphone

137. 

4-hydroxybutanoic acid (otherwise known as gamma-hydroxybutyrate or GHB), except when specified elsewhere in this Schedule

137A. 

4-hydroxybutyraldehyde when intended for human ingestion

137B. 

2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol otherwise known as CP 47,497

5 grams (or 20 Units)

138. 

Hydroxypethidine

138A. 

5-iodo-2,3-dihydro-1H-inden-2-amine otherwise known as 5-lodo-2-aminoindane or 5-IAI

25 grams (or 20 Units)

138B. 

2-((2-(4-iodo-2,5-dimethoxyphenyl)ethylamino)methyl)phenol (otherwise known as 25I-NBOH)

25g or 20 units

138C. 

2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-fluorophenyl)methyl]ethanamine (otherwise known as 25I-NBF)

25g or 20 units

138D. 

2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (otherwise known as 25I-NBOMe)

25g or 20 units

138E. 

2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2, 3-methylenedioxyphenyl)methyl]ethanamine (otherwise known as 25I-NBMD)

25g or 20 units

140. 

Isomethadone

141. 

Ketamine

142. 

Ketobemidone

143. 

Levamphetamine

25g

144. 

Levomethamphetamine

25g

145. 

Levomethorphan

146. 

Levomoramide

147. 

Levophenacylmorphan

148. 

Levorphanol

149. 

Lorazepam

150. 

Lysergic acid

151. 

Lysergide (otherwise known as lysergic acid diethylamide or LSD or LSD-25)

2mg or 20 units

152. 

Mecloqualone

153. 

Medazepam

154. 

Mestanolone

155. 

Mesterolone (otherwise known as methyldihydrotestosterone)

156. 

Metazocine

157. 

Methadone

158. 

Methandienone (otherwise known as methandrostenolone)

159. 

Methandriol

160. 

Methaqualone

161. 

Methcathinone

162. 

Methenolone

162AA. 

Methoxetamine

162A. 

5-methoxy-a-methyltryptamine (5-MeO-AMT)

162B. 

N-(2-methoxybenzyl)-1-[(7R)-3-bromo-2,5-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methanamine (otherwise known as 2CBCB-NBOMe)

25g or 20 units

163. 

2-methoxy-3,4-methylenedioxyamphetamine

25g

164. 

2-methoxy-4,5-methylenedioxyamphetamine

25g

165. 

4-methoxy-2,3-methylenedioxyamphetamine

25g

166. 

5-methoxy-3,4-methylenedioxyamphetamine (otherwise known as 5-methoxy-3,4-methylenedioxy-α-methylphenylethylamine or MMDA)

25g

167. 

2-methoxy-3,4-methylenedioxyphenylethylamine

168. 

3-methoxy-4,5-methylenedioxyphenylethylamine

169. 

4-methoxy-α-methylphenylethylamine (otherwise known as PMA)

169A. 

5-methoxy-N,N-diallyltryptamine

10 grams (or 20 Units)

170. 

4-methoxyphenylethylamine

170A. 

2-(2-methoxyphenyl)-1-(1-pentylindol-3-yl)ethanone otherwise known as JWH-250

5 grams (or 20 Units)

170B. 

2-(methylamino)-1-phenylpentan-1-one (otherwise known as pentedrone)

25g or 20 units

171. 

4-methylaminorex (otherwise known as 2-amino-4-methyl-5-phenyl-2-oxazoline or 4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine or ICE or Euphoria)

172. 

Methylamphetamine (otherwise known as methamphetamine or 1-phenyl-2-methylaminopropane)

(a) in individual packages

20 packages

(b) in any other form

25g

173. 

Methyldesorphine

174. 

Methyldihydromorphine

174A. 

N-methyl-6-7-dihydro-5H-cyclopenta[f][1,3]benzodioxol-6-amine otherwise known as 5,6-Methylenedioxy-N-methyl-2-aminoindane or MDMAI

25 grams (or 20 Units)

175. 

2,3-methylenedioxyamphetamine (otherwise known as 2,3-MDA)

(a) in individual packages

20 packages

(b) in any other form

25g

176. 

3,4-methylenedioxyamphetamine (otherwise known as MDA)

(a) in individual packages

20 packages

(b) in any other form

25g

177. 

N,α-dimethyl-3,4-(methylenedioxy) phenylethylamine (otherwise known as MDMA)

10g

178. 

N,α-dimethyl-2,3-(methylenedioxy) phenylethylamine (otherwise known as 2,3-MDMA)

10g

178A. 

3,4-methylenedioxyethylcathinone

25 grams (or 20 Units)

178B. 

3,4-methylenedioxymethcathinone

25 grams (or 20 Units)

179. 

3,4-methylenedioxyphenyl-2-propanone

179A. 

(RS)-1-(3,4-methylenedioxyphenyl)-2-(1-pyrrolidinyl)-1-butanone or 3’,4’-methylenedioxy-á-pyrrolidinobutiophenone (otherwise known as MDPBP)

25g or 20 units

179B. 

4-methylethcathinone (otherwise known as 4-MEC)

25g or 20 units

180. 

3-methylfentanyl

180A. 

4-methylmethcathinone

25 grams (or 20 Units)

181. 

N-[α-methyl-3,4-(methylenedioxy)phenethyl] hydroxylamine (otherwise known as N-hydroxy MDA)

182. 

N-methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine (otherwise known as MBDB)

183. 

2-methyl-3-morpholino-1,1-diphenylpropane carboxylic acid (moramide intermediate)

183M. 

Methylnaphthidate (otherwise known as HDMP-28)

184. 

Methylpentynol and other substituted alkynes for internal use

185. 

Methylphenidate

25g

186. 

1-methyl-4-phenylpiperidine-4-carboxylic acid (otherwise known as pethidine intermediate C)

187. 

1-methyl-4-phenyl-4-piperidinol propionate (otherwise known as 1-methyl-4-phenyl-4-propionoxypiperidine or MPPP)

188. 

Methyltestosterone

189. 

4-methylthioamphetamine

25g

190. 

3-methylthiofentanyl

191. 

Methyprylone

191A. 

Metonitazene

192. 

Metopon

193. 

Mibolerone

194. 

Midazolam

195. 

Morpheridine

196. 

Morphine

25g

197. 

Morphine methobromide

25g

198. 

Morphine-N-oxide

199. 

Muscimol

200. 

Myrophine

201. 

Nabilone

202. 

Nalbuphine

203. 

Nandrolone (otherwise known as nortestosterone)

203A. 

naphthalen-1-yl-(1-butylindol-3-yl)methanone otherwise known as JWH-073

5 grams (or 20 Units)

203B. 

naphthalen-1-yl-(1-pentylindol-3-yl)methanone otherwise known as JWH-018

5 grams (or 20 Units)

203C. 

1-naphthalen-2-yl-pyrrolidin-1-ylpentan-1-one otherwise known as Naphyrone O-2482

25 grams (or 20 Units)

203D. 

Naphthoylindoles

5g or 20 units

203E. 

Naphthoylpyrroles

5g or 20 units

203F. 

Naphthylmethylindenes

5g or 20 units

203G. 

Naphthylmethylindoles

5g or 20 units

204. 

Nicocodine

205. 

Nicodicodine

206. 

Nicomorphine

25g

207. 

Nitrazepam

209. 

Noracymethadol

210. 

Norcodeine

211. 

Norethandrolone

212. 

Norlevorphanol

213. 

Normethadone

214. 

Normorphine

215. 

Norpipanone

216. 

Opium (except the alkaloids noscapine and papaverine)

217. 

Oxandrolone

218. 

Oxazepam

219. 

Oxycodone

10g

220. 

Oxymesterone (otherwise known as hydroxymethyltestosterone)

221. 

Oxymetholone

222. 

Oxymorphone

223. 

Para-fluorofentanyl

224. 

Paraldehyde

225. 

Pentazocine

226. 

Pentobarbitone

227. 

Pethidine

10g

228. 

Phenadoxone

229. 

Phenampromide

230. 

Phenazocine

231. 

Phencyclidine (otherwise known as 1-(1-phenylcyclohexyl)piperidine or PCP)

232. 

Phendimetrazine

233. 

1-phenethyl-4-phenyl-4-piperidinol acetate (otherwise known as 1-phenylethyl-4-phenyl-4-acetoxypiperidine or PEPAP)

234. 

Phenmetrazine

235. 

Phenomorphan

236. 

Phenoperidine

237. 

Phentermine

237A. 

Phenylacetylindoles

5g or 20 units

238. 

4-phenylpiperidine-4-carboxylic acid ethyl ester (otherwise known as pethidine intermediate B)

239A. 

1-phenyl-2-(1-pyrrolidinyl)-1-pentanone (otherwise known as α-pyrrolidiniopentiophenone or α-PVP)

25 grams (or 20 units)

240. 

Pholcodine

241. 

Piminodine

242. 

Piritramide

243. 

Poppy straw concentrate (being the material arising when poppy straw has entered into a process for concentration of its alkaloids)

244. 

Prazepam

245. 

Proheptazine

246. 

Properidine

247. 

Propiram

248. 

Pseudoephedrine in a quantity greater than 6g

30g

248A. 

Psilocin (otherwise known as 4-HO-DMT)

5g or 20 units

249. 

Psilocybine

250. 

Quinalbarbitone

251. 

Racemethorphan

252. 

Racemoramide

253. 

Racemorphan

254. 

Remifentanil

255. 

Rolicyclidine (otherwise known as 1-(1- phenylcyclohexyl)pyrrolidine or PHP or PCPY)

255M. 

Salvinorin A (otherwise known as Methyl (2S, 4aR, 6aR, 7R, 9S, 10aS, 10bR)-9-Acetoxy-6a,10b-Dimethyl-4,10-Dioxo-Dodecahydro-2-(3-Furyl)-2H-Naphtho[2,1-c]Pyran-7-Carboxylate)

256. 

Secbutobarbitone

257. 

Somatropin (human growth hormone)

258. 

Stanolone (otherwise known as dihydrotestosterone)

259. 

Stanozolol

260. 

Sufentanil

260A. 

Synthetic cannabinomimetics

5g or 20 units

261. 

Temazepam

262. 

Tenocyclidine (otherwise known as 1-[1-(2-thienyl)cyclohexyl]-piperidine or TCP)

263. 

Testosterone (S4)

264. 

Tetrahydrocannabinols (otherwise known as THC), and their alkyl homologues, except –

(a) when separately specified in this Schedule; or

(b) when included in Schedule 8 of the Poisons List; or

(c) in hemp seed oil, containing 50mg/kg or less of tetrahydrocannabinols, when labelled "Not for internal use" or "Not to be taken"; or

(d) in products for purposes other than internal human use containing 50mg/kg or less of tetrahydrocannabinols

265. 

2,3,4,5-tetramethoxyamphetamine

25g

266. 

Thebacon

267. 

Thebaine

267A. 

1-(2-thienyl)-2-(methylamino)propane (otherwise known as methiopropamine or MPA)

25g or 20 units

268. 

Thiofentanyl

269. 

Tilidine

270. 

Trenbolone (S4)

271. 

Triazolam

272. 

Triclofos

272A. 

1-(3-trifluoromethylphenyl)piperazine (otherwise known as TFMPP)

273. 

Trimeperidine

274. 

2,3,4-trimethoxyamphetamine

25g

275. 

2,3,5-trimethoxyamphetamine

25g

276. 

2,3,6-trimethoxyamphetamine

25g

277. 

2,4,5-trimethoxyamphetamine

25g

278. 

2,4,6-trimethoxyamphetamine

25g

279. 

3,4,5-trimethoxy-a-methylphenylethylamine (otherwise known as TMA)

280. 

3,4,5-trimethoxyphenethylamine (otherwise known as mescaline) and other substances structurally derived from methoxyphenylethylamine and not separately specified in this Schedule except methoxyphenamine

281. 

1-(3,4,5-trimethoxyphenyl)-2-aminobutane

282. 

2,4,5-trimethoxyphenylethylamine

PART 3Controlled plants

Column 1

Item

Column 2

Controlled plant

Column 3

Trafficable quantity

1. 

Cannabis (other than as separated resin, oil or individual plants)

1kg

2. 

Cannabis (as individual plants)

20 plants

3. 

Cannabis (in individual packages)

20 packages

4. 

Cannabis oil

25g

5. 

Cannabis resin

25g

5A. 

Mitragyna speciosa

6. 

Poppy capsules (being seed pods, with or without seeds, of poppy plants)

500 capsules

7. 

Poppy plant material (being any processed or partly processed part of a poppy plant other than its seed)

100g

8. 

Poppy plants (Papaver bracteatum or Papaver somniferum)

500 plants

9. 

Salvia divinorum

PART 4Controlled precursors

Column 1

Item

Column 2

Controlled precursor

Column 3

Trafficable quantity

1. 

Acetic anhydrine

2.5kg

1A. 

Acetyl chloride

0.5kg

1B. 

Allybenzene

0.5kg

1C. 

Allylpyrocatechol

0.5kg

1D. 

Alpha-phenylacetoacetonitrile

0.5kg

1E. 

4-amino-butanoic acid

1.5kg

1F. 

Anthranilic acid

5.0kg

1G. 

1,3-benzodioxole

250ml

1H. 

5-bromo-1,3-benzodioxole

250ml

1I. 

Bromo safrole

300g

1J. 

1-chlorophenyl-2-aminopropane

1.25kg

1K. 

Any plant of the species Ephedra

2. 

Ephedrine

200g

3. 

Ergometrine

200mg

4. 

Ergotamine

280mg

4A. 

N-ethylephedrine

250g

4B. 

Ethyl phenyl acetate

4C. 

N-ethylpseudoephedrine

250g

4D. 

Gamma butyrolactone

1.5litres

4E. 

Gamma hydroxybutanoic acid

1.5litres

4F. 

4-hydroxybutanal

1.5litres

4G. 

4-hydroxy-butanoic acid lactone

1.5litres

4H. 

2-hydroxytetrahydrofuran

1.5litres

4I. 

Hypophosphite salts

0.25kg

4J. 

Hypophosphorous acid

450ml

5. 

Isosafrole

300g

6. 

Lysergic acid

100mg

7. 

Mercuric chloride

1milligram

8. 

3,4-methylenedioxybenzaldehyde

100g

8A. 

3,4-methylenedioxyphenylacetic acid

100g

8B. 

3,4-methylenedioxyphenylpropan-2-one

50g

8C. 

N-methylformamide

500ml

8D. 

N-methyl ephedrine

1.2kg

8E. 

N-methylpseudoephedrine

1.2kg

8F. 

Norpseudoephedrine

2.15kg

8G. 

N-phenethyl-4-piperidone

25g

9. 

1-phenyl-2-propanone

300g

9A. 

Phenylacetamide

500g

10. 

Phenylacetic acid

600g

10A. 

Phenylacetone

10B. 

1-phenyl-2-bromopropane

500g

10C. 

1-phenyl-2-chloropropane

1.15kg

10D. 

1-phenyl-2-iodopropane

500g

10E. 

1-phenyl-2-nitropropene

1.2kg

10F. 

1-phenyl-2-propanol

900ml

10G. 

1-phenyl-1-propanone

250ml

10H. 

1-phenyl-2-propanone oxime

1.0kg

10I. 

Phosphorus

100g

10J. 

Phosphorous acid

1.1litres

11. 

Piperonal

360g

12. 

Pseudoephedrine

200g

13. 

Safrole

300g

14. 

Sassafras oil

300ml

15. 

Thorium

1.0kg

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.